Concepedia

Christine Freedman

CF

Statistics

Publications

5

Citations

887

H-Index

5

Active since

2012

Affiliations

Massachusetts General Hospital(Current)

Shanxi Academy of Medical Sciences

Ministry of Education

Vanderbilt University Medical Center

Peking University Cancer Hospital

Christine Freedman is an author at Massachusetts General Hospital specializing in oncology, immunotherapy, and cancer immunotherapy.

Publications per year

2012–2022

5

Publications

5

High‐dose glucocorticoids for the treatment of ipilimumab‐induced hypophysitis is associated with reduced survival in patients with melanoma

Alexander T. Faje, Donald P. Lawrence, Keith T. Flaherty et al. · Cancer · 2018 · 483 citations · Full text

, , +13

Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti–PD-1 Monotherapy

Xue Bai, Jiani Hu, Allison Betof Warner et al. · Clinical Cancer Research · 2021 · 176 citations · Full text

, , +17

Patient Attitudes Toward the Use of Fecal Microbiota Transplantation in the Treatment of Recurrent Clostridium difficile Infection

Jonathan S. Zipursky, Tivon Sidorsky, Christine Freedman et al. · Clinical Infectious Diseases · 2012 · 159 citations · Full text

, , +9

Benefit and toxicity of programmed death-1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study

Xue Bai, Alexander N. Shoushtari, Allison Betof Warner et al. · British Journal of Dermatology · 2022 · 56 citations

, , +17

Radiological dynamics and SITC-defined resistance types of advanced melanoma during anti-PD-1 monotherapy: an independent single-blind observational study on an international cohort

Xue Bai, Michelle Kim, Gyulnara G. Kasumova et al. · Journal for ImmunoTherapy of Cancer · 2021 · 13 citations · Full text

, , +17

1–5 of 5